22 May 2018
By Dr Wendy Winnall - PCFA Research Team
Surgery to remove a localised prostate cancer can effectively cure that cancer. But unfortunately for men with higher-risk, localised prostate cancer, the disease can return. Radiotherapy is usually offered to patients with rising PSA levels after surgery. A new trial has tested the benefit of androgen deprivation therapy added to this radiotherapy. The results showed that only patients with specific disease features benefitted from this combined treatment.
To read the full article just log into the PCFA Online Community.
If you're not already a member, it is free and easy to join.
